Histopathological study of Uterine Leiomyoma in Hysterectomy Specimens

Authors

  • Sushma Bhatta KIST Medical College
  • Sunita Bhandari KIST Medical College
  • Bidur Prasad Osti KIST Medical College

DOI:

https://doi.org/10.3126/acclm.v3i2.20739

Keywords:

Degeneration, Hysterectomy, Uterine leiomyoma

Abstract

Background: Uterine leiomyoma is the most common benign neoplasm in women of reproductive age group. Hysterectomy is a mode of therapy in uterine Leiomyoma. The objective of this study was to evaluate the histopathological changes in hysterectomy specimens with uterine leiomyomas.

METHODS: This is a retrospective study of one hundred sixty eight patients who underwent hysterectomy for uterine leiomyoma.

Results: Uterine leiomyoma was most common in the age group of 41-50 years (54.76%). Most common location of leiomyoma was intramural (51.2%). Degenerative changes were seen in 10.72% cases. Hyaline degeneration was the most common type of degeneration (7.14%). Proliferative endometrium was the most common endometrial pattern (63.1%) in uterine leiomyoma. Associated malignant lesions were observed in 1.8 % cases of uterine leiomyoma.

CONCLUSION: Uterine leiomyoma is associated with degenerative changes and coexistent benign and malignant patholologies. Histopathological examination of hysterectomy specimens should be done to confirm the diagnosis and rule out other pathologies, especially malignant lesions.

Downloads

Download data is not yet available.
Abstract
2875
PDF
2926

Author Biographies

Sushma Bhatta, KIST Medical College

Department of Pathology

Sunita Bhandari, KIST Medical College

Department of Obstetrics and Gynecology

Bidur Prasad Osti, KIST Medical College

Department of Pathology

Downloads

Published

2018-08-22

How to Cite

Bhatta, S., Bhandari, S., & Osti, B. P. (2018). Histopathological study of Uterine Leiomyoma in Hysterectomy Specimens. Annals of Clinical Chemistry and Laboratory Medicine, 3(2), 16–20. https://doi.org/10.3126/acclm.v3i2.20739

Issue

Vol. 3 No. 2 (2017)

Section

Original Articles

License

Authors who publish with this journal agree to the following terms:

  1. The author transfers copyright to the Nepalese Association for Clinical Chemistry.
  2. The journal publishes the work under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal and under the same share-alike license used here.
  3. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  4. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).